相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer
Ildiko Kocsmar et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Use and Validation of the AUA/SUO Risk Grouping for Nonmuscle Invasive Bladder Cancer in a Contemporary Cohort
Chad R. Ritch et al.
JOURNAL OF UROLOGY (2020)
Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer
Emanuela Trenti et al.
CANCER CYTOPATHOLOGY (2020)
Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European Study
Morgan Roupret et al.
JOURNAL OF UROLOGY (2020)
The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence
Mariangela Mancini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients
Caroline A. Sieverink et al.
DIAGNOSTICS (2020)
A Novel, non-invasive Test Enabling Bladder Cancer Detection in Urine Sediment of Patients Presenting with Haematuria-A Prospective Multicentre Performance Evaluation of ADXBLADDER
Tim Dudderidge et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study
Angela B. Smith et al.
BJU INTERNATIONAL (2019)
Cost-effectiveness of surveillance schedules in older adults with non-muscle-invasive bladder cancer
Eveline A. M. Heijnsdijk et al.
BJU INTERNATIONAL (2019)
Mixed-methods approach to exploring patients' perspectives on the acceptability of a urinary biomarker test in replacing cystoscopy for bladder cancer surveillance
Wei Shen Tan et al.
BJU INTERNATIONAL (2019)
The Impact of Narrow Band Imaging in the Detection and Resection of Bladder Tumor in Transitional Cell Carcinoma of the Bladder: A Prospective, Blinded, Sequential Intervention Randomized Controlled Trial
Partho Mukherjee et al.
UROLOGY (2019)
Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy
Badrinath Konety et al.
EUROPEAN UROLOGY (2019)
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018
Yair Lotan et al.
NATURE REVIEWS UROLOGY (2019)
Overuse of Cystoscopic Surveillance Among Patients With Low-risk Non-Muscle-invasive Bladder Cancer - A National Study of Patient, Provider, and Facility Factors
David S. Han et al.
UROLOGY (2019)
Augmented Bladder Tumor Detection Using Deep Learning
Eugene Shkolyar et al.
EUROPEAN UROLOGY (2019)
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer
F. Johannes P. van Valenberg et al.
EUROPEAN UROLOGY (2019)
Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories
Matthew Mossanen et al.
WORLD JOURNAL OF UROLOGY (2019)
Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)
Valeria Panebianco et al.
EUROPEAN UROLOGY (2018)
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project
Rodolfo Hurle et al.
JOURNAL OF UROLOGY (2018)
Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria?
Wei Shen Tan et al.
JOURNAL OF UROLOGY (2018)
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
Siamak Daneshmand et al.
JOURNAL OF UROLOGY (2018)
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
Francesco Soria et al.
WORLD JOURNAL OF UROLOGY (2018)
The role of fluorescence in situ hybridization to predict patient response to intravesical Bacillus Calmette-Guerin therapy for bladder cancer A diagnostic meta-analysis and systematic review
Yige Bao et al.
MEDICINE (2018)
Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial
J. Alfred Witjes et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study
Laimonis Kavalieris et al.
JOURNAL OF UROLOGY (2017)
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
Willemien Beukers et al.
JOURNAL OF UROLOGY (2017)
Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Guerin therapy for intermediate- and high-risk non-muscleinvasive bladder cancer
Esmee I. M. L. Liem et al.
MEDICAL ONCOLOGY (2017)
Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers-a Prospective Double-Blind Clinical Study
Paramananthan Mariappan et al.
UROLOGY (2017)
'Real-life experience': recurrence rate at 3 years with Hexvix® photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC-a prospective controlled study
Kevin M. Gallagher et al.
WORLD JOURNAL OF UROLOGY (2017)
Correlation of Transabdominal Ultrasonography and Cystoscopy in Follow-up of Patients with Non-muscle Invasive Bladder Cancer
Ahluwalia Puneet et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2017)
Economic Burden of Bladder Cancer Across the European Union
Jose Leal et al.
EUROPEAN UROLOGY (2016)
The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results
Seiji Naito et al.
EUROPEAN UROLOGY (2016)
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
Richard J. Sylvester et al.
EUROPEAN UROLOGY (2016)
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin
Samantha Cambier et al.
EUROPEAN UROLOGY (2016)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2016)
Therapeutic Options in High-risk Non-muscle-invasive Bladder Cancer During the Current Worldwide Shortage of Bacille Calmette-Guerin
A. Hugh Mostafid et al.
EUROPEAN UROLOGY (2015)
Long-term Cancer-specific Outcomes of TaG1 Urothelial Carcinoma of the Bladder
Malte Rieken et al.
EUROPEAN UROLOGY (2014)
Disease Specific Mortality in Patients with Low Risk Bladder Cancer and the Impact of Cystoscopic Surveillance
Kate D. Linton et al.
JOURNAL OF UROLOGY (2013)
Should Follow-up Cystoscopy in Bacillus Calmette-Guerin-Treated Patients Continue After Five Tumour-Free Years?
Sten Holmang et al.
EUROPEAN UROLOGY (2012)
Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer
G. Mowatt et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
Late Recurrence and Progression in Non-muscle-invasive Bladder Cancers After 5-year Tumor-free Periods
Kazuhiro Matsumoto et al.
UROLOGY (2010)
The present and future burden of urinary bladder cancer in the world
Martine Ploeg et al.
WORLD JOURNAL OF UROLOGY (2009)
Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: A decision analytical approach
Y Lotan et al.
JOURNAL OF UROLOGY (2002)
分享论文
